These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36561911)

  • 1. Challenges Associated with Addressing Counterfeit Medicines in Nigeria: An Exploration of Pharmacists' Knowledge, Practices, and Perceptions.
    Adigwe OP; Onavbavba G; Wilson DO
    Integr Pharm Res Pract; 2022; 11():177-186. PubMed ID: 36561911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pharmacists in eliminating counterfeit medicines in Nigeria.
    Adigwe OP
    Front Public Health; 2023; 11():1170929. PubMed ID: 37674683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community pharmacists' perceptions, awareness and practices regarding counterfeit medicines: a cross-sectional survey in Alexandria, Egypt.
    Bashir A; Galal S; Ramadan A; Wahdan A; El-Khordagui L
    East Mediterr Health J; 2020 May; 26(5):556-564. PubMed ID: 32538449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceived Prevalence, Awareness and Attitude towards Counterfeit Medicines among Community Pharmacists of Kathmandu Valley: A Descriptive Cross-sectional Study.
    Kafle S; Jha N; Bhandary S; Ravi Shankar P
    JNMA J Nepal Med Assoc; 2024 Jun; 62(275):427-432. PubMed ID: 39369416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of knowledge, attitude, and practice on substandard and counterfeit pharmaceutical products among pharmacy professionals in Gondar City, North-West Ethiopia.
    Worku MC; Mitku ML; Ayenew W; Limenh LW; Ergena AE; Geremew DT; Bizuneh GK; Tefera BB; Mekonnen BA; Anagaw YK
    Curr Pharm Teach Learn; 2024 Oct; 16(10):102140. PubMed ID: 39002340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combatting Substandard and Counterfeit Medicines in the Nigerian Drug Market: How Industrial Pharmacists Can Rise Up to the Challenge.
    Okereke M; Anukwu I; Solarin S; Ohuabunwa MS
    Innov Pharm; 2021; 12(3):. PubMed ID: 35601591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consumer and Community Pharmacists' Perceptions of Online Pharmacy Services in Uyo Metropolis, Nigeria.
    Ndem E; Udoh A; Awofisayo O; Bafor E
    Innov Pharm; 2019; 10(3):. PubMed ID: 34007568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The fight against counterfeit medicines in Africa: experience and role of pharmacists].
    Chauvé M
    C R Biol; 2008 Dec; 331(12):982-5. PubMed ID: 19027699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counterfeit drug demand: perceptions of policy makers and community pharmacists in Sudan.
    Alfadl AA; Hassali MA; Ibrahim MI
    Res Social Adm Pharm; 2013; 9(3):302-10. PubMed ID: 22835708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacists' knowledge of substandard and falsified medicines in clinical practice: a cross-sectional survey in Saudi Arabia.
    Bashayr Ali A; Barrett R
    Int J Pharm Pract; 2023 Apr; 31(2):176-182. PubMed ID: 36748987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point-of-Care Anti-Counterfeit Medicines Technologies: Awareness and Utilization among Medical Practitioners in Eastern Nigeria.
    Iloh GU; Akodu BA; Emeka EA; Obi IV
    West Afr J Med; 2021 Nov; Vol. 38(11):1029-1035. PubMed ID: 34918894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health Professionals and Pharmacists Awareness and Attitude Towards Counterfeit Medicine.
    Chaudhary S
    J Nepal Health Res Counc; 2023 Dec; 21(2):219-225. PubMed ID: 38196211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How the quality of essential medicines is perceived and maintained through the pharmaceutical supply chain: A perspective from stakeholders in Nigeria.
    Amadi C; Tsui EK
    Res Social Adm Pharm; 2019 Nov; 15(11):1344-1357. PubMed ID: 30509851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions and practices of pharmaceutical wholesalers surrounding counterfeit medicines in a developing country: a baseline survey.
    Khan MH; Akazawa M; Dararath E; Kiet HB; Sovannarith T; Nivanna N; Yoshida N; Kimura K
    BMC Health Serv Res; 2011 Nov; 11():306. PubMed ID: 22074046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Care Providers' Knowledge, Attitude and Practice Toward Counterfeit Medicines in Mizan-Tepi University Teaching Hospital, South West Ethiopia: A Cross-Sectional Study.
    Siraj J; Gebre A; Shafi M; Birhan A; Ejeta F; Hambisa S
    Inquiry; 2022; 59():469580221108335. PubMed ID: 35942588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I (Don't) want to consume counterfeit medicines: exploratory study on the antecedents of consumer attitudes toward counterfeit medicines.
    Ofori-Parku SS; Park SE
    BMC Public Health; 2022 Jun; 22(1):1094. PubMed ID: 35650557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supply chain management of health commodities for reducing global disease burden.
    Chukwu OA; Ezeanochikwa VN; Eya BE
    Res Social Adm Pharm; 2017; 13(4):871-874. PubMed ID: 27720436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substandard and counterfeit medicines: a systematic review of the literature.
    Almuzaini T; Choonara I; Sammons H
    BMJ Open; 2013 Aug; 3(8):e002923. PubMed ID: 23955188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Counterfeit medicines--Japan and the world].
    Sato D
    Yakugaku Zasshi; 2014; 134(2):213-22. PubMed ID: 24492225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.